Backed by advancing endoscopic care and growing demand for non-surgical obstruction management, the gastrointestinal stent market was valued at USD 586.23 million in the base year 2025 and is projected to reach USD 618.54 million in 2026 and USD 958.81 million by 2034, registering a CAGR of 5.62% during the forecast period 2026–2034. Prominent players include Merit Medical Systems, Inc.,...